BAKER BROS ADVISORS LLC Insider Trading for January 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for BAKER BROS ADVISORS LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of BAKER BROS ADVISORS LLC for January 2018.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 22 2018 | BGNE | BeiGene, Ltd. | BAKER BROS. ADVISORS LP | Director | Buy | P | 101.00 | 1,645,148 | 166,159,948 | 5,121,404 | 3.5 M to 5.1 M (+47.33 %) |
Jan 22 2018 | BGNE | BeiGene, Ltd. | BAKER BROS. ADVISORS LP | Director | Buy | P | 101.00 | 335,050 | 33,840,050 | 708,025 | 373 K to 708 K (+89.83 %) |
Jan 19 2018 | BLCM | BELLICUM PHARMACEU ... | BAKER BROS. ADVISORS LP | 10% Owner | Sell | S | 7.91 | 4,136 | 32,715 | 58,131 | 62.3 K to 58.1 K (-6.64 %) |
Jan 19 2018 | BLCM | BELLICUM PHARMACEU ... | BAKER BROS. ADVISORS LP | 10% Owner | Sell | S | 7.91 | 265,708 | 2,101,671 | 3,734,776 | 4 M to 3.7 M (-6.64 %) |
Jan 19 2018 | BLCM | BELLICUM PHARMACEU ... | BAKER BROS. ADVISORS LP | 10% Owner | Sell | S | 7.91 | 25,517 | 201,832 | 358,671 | 384.2 K to 358.7 K (-6.64 %) |
Jan 19 2018 | BLCM | BELLICUM PHARMACEU ... | BAKER BROS. ADVISORS LP | 10% Owner | Sell | S | 8.12 | 4,548 | 36,910 | 62,267 | 66.8 K to 62.3 K (-6.81 %) |
Jan 19 2018 | BLCM | BELLICUM PHARMACEU ... | BAKER BROS. ADVISORS LP | 10% Owner | Sell | S | 8.12 | 292,168 | 2,371,148 | 4,000,484 | 4.3 M to 4 M (-6.81 %) |
Jan 19 2018 | BLCM | BELLICUM PHARMACEU ... | BAKER BROS. ADVISORS LP | 10% Owner | Sell | S | 8.12 | 28,058 | 227,710 | 384,188 | 412.2 K to 384.2 K (-6.81 %) |
Jan 19 2018 | BLCM | BELLICUM PHARMACEU ... | BAKER BROS. ADVISORS LP | 10% Owner | Sell | S | 8.63 | 3,649 | 31,476 | 66,815 | 70.5 K to 66.8 K (-5.18 %) |
Jan 19 2018 | BLCM | BELLICUM PHARMACEU ... | BAKER BROS. ADVISORS LP | 10% Owner | Sell | S | 8.63 | 234,437 | 2,022,230 | 4,292,652 | 4.5 M to 4.3 M (-5.18 %) |
Jan 19 2018 | BLCM | BELLICUM PHARMACEU ... | BAKER BROS. ADVISORS LP | 10% Owner | Sell | S | 8.63 | 22,514 | 194,204 | 412,246 | 434.8 K to 412.2 K (-5.18 %) |
Jan 04 2018 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 2.21 | 9,333 | 20,626 | 163,831 | 154.5 K to 163.8 K (+6.04 %) |
Jan 04 2018 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 2.21 | 9,333 | 20,626 | 16,566,806 | 16.6 M to 16.6 M (+0.06 %) |
Jan 04 2018 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 2.21 | 9,333 | 20,626 | 1,851,950 | 1.8 M to 1.9 M (+0.51 %) |
Jan 03 2018 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Grant | A | 94.71 | 200 | 18,942 | 789,778 | 789.6 K to 789.8 K (+0.03 %) |
Jan 03 2018 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Grant | A | 94.71 | 200 | 18,942 | 29,247,709 | 29.2 M to 29.2 M (0.00 %) |
Jan 03 2018 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Grant | A | 94.71 | 200 | 18,942 | 4,387,180 | 4.4 M to 4.4 M (0.00 %) |